# Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients

> **NCT04054128** · PHASE4 · UNKNOWN · sponsor: **Hospital General "Dr. Miguel Silva" de Morelia** · enrollment: 60 (actual)

## Conditions studied

- End Stage Renal Disease
- Vascular Access Complication
- Catheter Complications
- Hemodialysis Access Failure
- Hemodialysis Catheter Infection

## Interventions

- **DRUG:** Sodium Bicarbonate 7.5% Injection
- **DRUG:** Heparin Sodium, 1000 Units/mL Injectable Solution 1

## Key facts

- **NCT ID:** NCT04054128
- **Lead sponsor:** Hospital General "Dr. Miguel Silva" de Morelia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-11
- **Primary completion:** 2020-02-20
- **Final completion:** 2020-09-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-04-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04054128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04054128, "Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04054128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*